286 related articles for article (PubMed ID: 25989143)
1. Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1.
Dawson N; Kurihara M; Thomson DM; Winchester CL; McVie A; Hedde JR; Randall AD; Shen S; Seymour PA; Hughes ZA; Dunlop J; Brown JT; Brandon NJ; Morris BJ; Pratt JA
Transl Psychiatry; 2015 May; 5(5):e569. PubMed ID: 25989143
[TBL] [Abstract][Full Text] [Related]
2. Sustained NMDA receptor hypofunction induces compromised neural systems integration and schizophrenia-like alterations in functional brain networks.
Dawson N; Xiao X; McDonald M; Higham DJ; Morris BJ; Pratt JA
Cereb Cortex; 2014 Feb; 24(2):452-64. PubMed ID: 23081884
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia.
Anticevic A; Corlett PR; Cole MW; Savic A; Gancsos M; Tang Y; Repovs G; Murray JD; Driesen NR; Morgan PT; Xu K; Wang F; Krystal JH
Biol Psychiatry; 2015 Mar; 77(6):569-80. PubMed ID: 25281999
[TBL] [Abstract][Full Text] [Related]
4. Map2k7 Haploinsufficiency Induces Brain Imaging Endophenotypes and Behavioral Phenotypes Relevant to Schizophrenia.
Openshaw RL; Thomson DM; Thompson R; Penninger JM; Pratt JA; Morris BJ; Dawson N
Schizophr Bull; 2020 Jan; 46(1):211-223. PubMed ID: 31219577
[TBL] [Abstract][Full Text] [Related]
5. Neurophysiological modification of CA1 pyramidal neurons in a transgenic mouse expressing a truncated form of disrupted-in-schizophrenia 1.
Booth CA; Brown JT; Randall AD
Eur J Neurosci; 2014 Apr; 39(7):1074-90. PubMed ID: 24712988
[TBL] [Abstract][Full Text] [Related]
6. Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction.
Ponserre M; Ionescu TM; Franz AA; Deiana S; Schuelert N; Lamla T; Williams RH; Wotjak CT; Hobson S; Dine J; Omrani A
Neuropharmacology; 2024 Aug; 254():109970. PubMed ID: 38685343
[TBL] [Abstract][Full Text] [Related]
7. Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks.
Dawson N; McDonald M; Higham DJ; Morris BJ; Pratt JA
Neuropsychopharmacology; 2014 Jun; 39(7):1786-98. PubMed ID: 24492765
[TBL] [Abstract][Full Text] [Related]
8. Transient Knock-Down of Prefrontal DISC1 in Immune-Challenged Mice Causes Abnormal Long-Range Coupling and Cognitive Dysfunction throughout Development.
Xu X; Chini M; Bitzenhofer SH; Hanganu-Opatz IL
J Neurosci; 2019 Feb; 39(7):1222-1235. PubMed ID: 30617212
[TBL] [Abstract][Full Text] [Related]
9. Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems.
Dawson N; Morris BJ; Pratt JA
Schizophr Bull; 2013 Mar; 39(2):366-77. PubMed ID: 22114100
[TBL] [Abstract][Full Text] [Related]
10. Facilitated glutamate release at Schaffer collateral to CA1 synapses has access to an exclusive population of NMDA receptors.
Scullin CS; Schiess AR; Donald Partridge L
Brain Res; 2015 Oct; 1622():22-35. PubMed ID: 26100337
[TBL] [Abstract][Full Text] [Related]
11. Effect of VGLUT inhibitors on glutamatergic synaptic transmission in the rodent hippocampus and prefrontal cortex.
Neale SA; Copeland CS; Salt TE
Neurochem Int; 2014 Jul; 73():159-65. PubMed ID: 24121008
[TBL] [Abstract][Full Text] [Related]
12. Losing control under ketamine: suppressed cortico-hippocampal drive following acute ketamine in rats.
Moran RJ; Jones MW; Blockeel AJ; Adams RA; Stephan KE; Friston KJ
Neuropsychopharmacology; 2015 Jan; 40(2):268-77. PubMed ID: 25053181
[TBL] [Abstract][Full Text] [Related]
13. Ketamine Administration During the Second Postnatal Week Alters Synaptic Properties of Fast-Spiking Interneurons in the Medial Prefrontal Cortex of Adult Mice.
Jeevakumar V; Kroener S
Cereb Cortex; 2016 Mar; 26(3):1117-29. PubMed ID: 25477370
[TBL] [Abstract][Full Text] [Related]
14. Pathogenicity of lupus anti-ribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model.
Segovia-Miranda F; Serrano F; Dyrda A; Ampuero E; Retamal C; Bravo-Zehnder M; Parodi J; Zamorano P; Valenzuela D; Massardo L; van Zundert B; Inestrosa NC; González A
Arthritis Rheumatol; 2015 Jun; 67(6):1598-610. PubMed ID: 25709106
[TBL] [Abstract][Full Text] [Related]
15. Glutamate dehydrogenase deficiency disrupts glutamate homeostasis in hippocampus and prefrontal cortex and impairs recognition memory.
Lander SS; Chornyy S; Safory H; Gross A; Wolosker H; Gaisler-Salomon I
Genes Brain Behav; 2020 Jul; 19(6):e12636. PubMed ID: 31898404
[TBL] [Abstract][Full Text] [Related]
16. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia.
Ohnuma T; Kato H; Arai H; Faull RL; McKenna PJ; Emson PC
Neuroreport; 2000 Sep; 11(14):3133-7. PubMed ID: 11043537
[TBL] [Abstract][Full Text] [Related]
18. Interneuron NMDA Receptor Ablation Induces Hippocampus-Prefrontal Cortex Functional Hypoconnectivity after Adolescence in a Mouse Model of Schizophrenia.
Alvarez RJ; Pafundo DE; Zold CL; Belforte JE
J Neurosci; 2020 Apr; 40(16):3304-3317. PubMed ID: 32205341
[TBL] [Abstract][Full Text] [Related]
19. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice.
Errico F; D'Argenio V; Sforazzini F; Iasevoli F; Squillace M; Guerri G; Napolitano F; Angrisano T; Di Maio A; Keller S; Vitucci D; Galbusera A; Chiariotti L; Bertolino A; de Bartolomeis A; Salvatore F; Gozzi A; Usiello A
Transl Psychiatry; 2015 Feb; 5(2):e512. PubMed ID: 25689573
[TBL] [Abstract][Full Text] [Related]
20. Adolescent stress leads to glutamatergic disturbance through dopaminergic abnormalities in the prefrontal cortex of genetically vulnerable mice.
Matsumoto Y; Niwa M; Mouri A; Noda Y; Fukushima T; Ozaki N; Nabeshima T
Psychopharmacology (Berl); 2017 Oct; 234(20):3055-3074. PubMed ID: 28756461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
